Guillermo Rocha

Guillermo Rocha

Auto-generated profile, based on publicly available information

Guillermo Rocha

Department of Ophthalmology and Visual Sciences, McGill University, QC, Canada

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2016 in Clinical Ophthalmology
Verified
Journal Article
Open access
PDF file
JCJeffrey Chu
Jeffrey Chu
JJJason J Jones
Jason J Jones
JGJacob Graham
Jacob Graham
SZSerge Zaluski
Serge Zaluski
GRGuillermo Rocha
Guillermo Rocha
Purpose: The aim of this study was to evaluate the operational impact of using preloaded intraocular lens (IOL) delivery systems compared with manually loaded IOL delivery processes during routine cataract surgeries. Methods: Time and motion data, staff and surgery schedules, and cost accounting reports were collected across three sites located in the US, France, and Canada. Time and motion data were collected for manually loaded IOL processes and preloaded IOL delivery systems over four surgery days. Staff and surgery schedules and cost accounting reports were collected during the 2 months prior and after introduction of the preloaded IOL delivery system. Results: The study included a total of 154 routine cataract surgeries across all three sites. Of these, 77 surgeries were performed using a preloaded IOL delivery system, and the remaining 77 surgeries were performed using a manual IOL delivery process. Across all three sites, use of the preloaded IOL delivery system significantly decreased mean total case time by 6.2%–12.0% (P<0.001 for data from Canada and the US and P<0.05 for data from France). Use of the preloaded delivery system also decreased surgeon lens time, surgeon delays, and eliminated lens touches during IOL preparation.
Conclusion:
Compared to a manual IOL delivery process, use of a preloaded IOL delivery system for cataract surgery reduced total case time, total surgeon lens time, surgeon delays, and eliminated IOL touches. The time savings provided by the preloaded IOL delivery system provide an opportunity for sites to improve routine cataract surgery throughput without impacting surgeon or staff capacity.

7 November 2023 in Graefe's Archive for Clinical and Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
EMEkaterina Milovanova
Ekaterina Milovanova
SGStanislav Gomon
Stanislav Gomon
GRGuillermo Rocha
Guillermo Rocha

1 May 2024 in Journal of Cataract & Refractive Surgery
Verified
Journal Article
Closed access
BTBrendan Tao
Brendan Tao
JXJim Shenchu Md(C) Xie
Jim Shenchu Md(C) Xie
MXManvis Bsc Xia
Manvis Bsc Xia
SMSahand Bmsc Marzban
Sahand Bmsc Marzban
AVAmir R. Md Vosoughi
Amir R. Md Vosoughi
GRGuillermo Rocha
Guillermo Rocha
Purpose: To investigate sex, racial, and ethnic disparities in patient enrollment across cataract trials registered in the United States. Setting: Participants enrolled in high-quality (reduced risk of bias), U.S.-registered (on ClinicalTrials.gov), cataract-related randomized controlled trials (RCTs). RCTs must be completed, have used double or greater masking, and have published results through the registry or a scholarly journal. Design: Cross-sectional database study. Methods: Trial (study sponsor country, study site location, trial initiation year, study phase, and study masking) and demographic data (sex, race, and ethnicity according to U.S. reporting guidelines) were collected. The Global Burden of Disease database provided sex-based cataract disease burdens. Pooled participation-to-prevalence ratios (PPRs) with 95% CIs were calculated for female sex, with values between 0.8 and 1.2 constituting sufficient study enrollment. Kruskal-Wallis tests (α = 0.05) with subsequent post hoc comparisons were used to evaluate demographic representations stratified by trial characteristics. Results: From 864 records, 100 clinical trials (N = 67 874) were identified, of which 97 (N = 67 697) reported sex demographics with a pooled female PPR of 0.89 (95% CI, 0.85-0.94). Of the 67 697 total participants, the absolute female enrollment was 19 062 (28.16%). Ethnicity and race were reported in 9 (N = 1792) and 26 trials (N = 23 181), respectively. Among trials that reported race, most were White (N = 19 574; 84.44%). Conclusions: High-quality, U.S.-registered, cataract trials enrolled acceptable proportions of women. However, the absolute number of female and racialized participants was low. Race and ethnicity were underreported. Disparity trends predominately held across secondary variables. To promote generalizability, future trials should pursue equitable demographic enrollment.

1 August 2025 in Journal of Cataract & Refractive Surgery
Verified
Journal Article
Closed access
AHAngelica Bsc Hanna
Angelica Bsc Hanna
JAJames Jacob Armstrong
James Jacob Armstrong
EKEfstathia Kiatos-Tsioros
Efstathia Kiatos-Tsioros
GRGuillermo Rocha
Guillermo Rocha
CHCindy M.L. Hutnik
Cindy M.L. Hutnik
IAIqbal Ike K. Ahmed
Iqbal Ike K. Ahmed
Topic: This review assesses the effectiveness of intravenous (IV) sedation compared with non-IV sedation for routine cataract surgery. Clinical Relevance: Cataract surgery is a safe and routinely performed surgery. Sedation practices vary, with centers providing IV, oral, or no sedation for surgery. Improving sedation practices may have significant implications for patient safety, patient experience, and health system efficiency. Methods: MEDLINE, Embase, Cochrane Library, BIOSIS, Web of Science, and CINAHL were searched from inception to July 2024 for relevant articles containing original data. Randomized controlled trials that compared IV with oral or no sedation and (1) used a validated pain scale to report on pain or (2) reported on perioperative complications were included. A random-effects meta-analysis was conducted. Odds ratios (ORs), standard mean differences (SMDs), 95% CIs, and I 2 statistics were reported. The review was registered in PROSPERO (CRD42024582495), and PRISMA guidelines were followed. Results: 12 randomized controlled trials including 1130 patients were included in the meta-analysis. IV sedation was associated with significantly decreased pain compared with no sedation (SMD, −0.98; 95% CI, −1.68 to −0.29). Comparing IV and oral sedation, however, there was no difference in patient-reported pain (SMD, −0.54; 95% CI, −1.60 to 0.52). Analysis of intraoperative complications showed that there was no significant difference in complications between patients receiving IV and oral sedation (OR, 0.68; 95% CI, 0.27-1.73). Conclusions: For routine cataract surgery, IV sedation was associated with less pain than no sedation, but oral and IV sedation provided comparable pain control. Perioperative complications occur at similar rates regardless of sedation modality. These findings may help to inform sedation practices for cataract surgery.

28 May 2021 in Canadian Journal of Ophthalmology
Verified
Journal Article
Closed access
PDF file
PYPavel Yarmak
Pavel Yarmak
MLMatthew Lee-Wing
Matthew Lee-Wing
GRGuillermo Rocha
Guillermo Rocha